Intrexon Corporation;University of Pittsburgh-Of The Commonwealth System Of Higher Education
发明人:
Mark BRAUGHLER,Prasanna Kumar,Walter J. Storkus,Hideho Okada
申请号：
US15591468
公开号：
US20170312315A1
申请日:
2017.05.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL-12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.
